Thu, Jan 29, 2015, 2:03 AM EST - U.S. Markets open in 7 hrs 27 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • pokeysun pokeysun Nov 1, 2013 2:47 PM Flag

    stock taking a beating

    why????

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Funds are in risk off buying mode since the debt/shutdown decable/close on 3Q. Celldex is pure high potential independent biotech with multiple shots on goal this quarter. An envious position to be in, but risk still exists whilst we wait on the data for several drugs in the pipeline. Everyone is waiting on the next news cycle that will trigger the next (likely big) move. As a long and strong stakeholder, my money is on positive data/news coming in for our adjuvant to checkpoint inhibition (CDX-1127), Rindo + Avastin combination therapy for refractory glioblastoma, the complement inhibitor (CDX-1135) for ultra orphan indication of dense deposits disease AND (yes AND) start of accelerated phase III for (CDX-010) for breast cancer. I know it seems overly optimistic, but it's well within the realm of possibilty that most if not all of these come in positive before the end of this year! Most of us here think that despite the recent pps decline that you want to be in these shares ahead of these catalysts and buy more as they come in like ducks in a row. A huge run into next year is possible. An independent biotech with all this going for it is worth much more and the risk/reward is also much better here than most realize.

      Sentiment: Strong Buy

    • It appears the institutions are getting out and those are the guys who have the best insight. It seems for some reason they can predict outcomes better than retail owners. Can't imagine why

    • Nothing changed with their PIPELINE. Just have to hold em if you got em.

      Sentiment: Hold

 
CLDX
22.27-1.44(-6.07%)Jan 28 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Exelixis, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
ABIOMED, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST